Volume 5, Issue 1

New Evidence About MS Risk Factors

In this issue:

What does the recent research say about the risk factors for developing MS? How significant is past Epstein-Barr virus/infectious mononucleosis infection? Which modifiable lifestyle and environmental risk factors have been identified? What do the newer findings indicate about the contribution of race and genotype? 

These are some of the questions Dr. Melanie Ward from the West Virginia University’s Rockefeller Neuroscience Institute addresses in this issue of eMultipleSclerosis Review. 

Learning objectives:

  • Describe the role of both modifiable and nonmodifiable risk factors in MS.  
  • Explain how increased clinician understanding of modifiable risk factors can improve patient outcomes. 

Author:

Melanie Ward, MD
Melanie Ward, MD

Assistant Professor
West Virginia University Rockefeller Neuroscience Institute
Morgantown, WV

Program Directors:

Pavan Bhargava, MBBS, MD

Assistant Professor
Department of Neurology
Johns Hopkins School of Medicine
Baltimore, MD

Lisa Fox, PA-C, MPAS

Department of Neurology
Johns Hopkins Hospital
Baltimore, MD

Michael Kornberg, MD, PhD

Assistant Professor
Department of Neurology
Johns Hopkins School of Medicine
Baltimore, MD

Length of activity:

1.0 hour Physicians
1.0 contact hour Nurses

Launch date: February 2, 2023
Expiration date: February 1, 2025